Xing Zizhuo, Kenty Brian M, Li Zheng Jian, Lee Steven S
Process Sciences, Biologics Manufacturing and Process Development, Worldwide Medicines Group, Bristol-Myers Squibb Company, Syracuse, NY 13221-4755, USA.
Biotechnol Bioeng. 2009 Jul 1;103(4):733-46. doi: 10.1002/bit.22287.
Bioprocess scale-up is a fundamental component of process development in the biotechnology industry. When scaling up a mammalian cell culture process, it is important to consider factors such as mixing time, oxygen transfer, and carbon dioxide removal. In this study, cell-free mixing studies were performed in production scale 5,000-L bioreactors to evaluate scale-up issues. Using the current bioreactor configuration, the 5,000-L bioreactor had a lower oxygen transfer coefficient, longer mixing time, and lower carbon dioxide removal rate than that was observed in bench scale 5- and 20-L bioreactors. The oxygen transfer threshold analysis indicates that the current 5,000-L configuration can only support a maximum viable cell density of 7 x 10(6) cells mL(-1). Moreover, experiments using a dual probe technique demonstrated that pH and dissolved oxygen gradients may exist in 5,000-L bioreactors using the current configuration. Empirical equations were developed to predict mixing time, oxygen transfer coefficient, and carbon dioxide removal rate under different mixing-related engineering parameters in the 5,000-L bioreactors. These equations indicate that increasing bottom air sparging rate is more efficient than increasing power input in improving oxygen transfer and carbon dioxide removal. Furthermore, as the liquid volume increases in a production bioreactor operated in fed-batch mode, bulk mixing becomes a challenge. The mixing studies suggest that the engineering parameters related to bulk mixing and carbon dioxide removal in the 5,000-L bioreactors may need optimizing to mitigate the risk of different performance upon process scale-up.
生物过程放大是生物技术产业过程开发的一个基本组成部分。在放大哺乳动物细胞培养过程时,考虑混合时间、氧气传递和二氧化碳去除等因素很重要。在本研究中,在生产规模的5000升生物反应器中进行了无细胞混合研究,以评估放大问题。使用当前的生物反应器配置,5000升生物反应器的氧气传递系数较低、混合时间较长且二氧化碳去除率低于在实验室规模的5升和20升生物反应器中观察到的情况。氧气传递阈值分析表明,当前的5000升配置仅能支持最大活细胞密度为7×10⁶个细胞/毫升。此外,使用双探针技术的实验表明,采用当前配置的5000升生物反应器中可能存在pH值和溶解氧梯度。开发了经验方程来预测5000升生物反应器中不同混合相关工程参数下的混合时间、氧气传递系数和二氧化碳去除率。这些方程表明,在改善氧气传递和二氧化碳去除方面,提高底部空气喷射速率比增加功率输入更有效。此外,随着分批补料模式下运行的生产生物反应器中液体体积的增加,整体混合成为一项挑战。混合研究表明,5000升生物反应器中与整体混合和二氧化碳去除相关的工程参数可能需要优化,以降低过程放大时性能差异的风险。